全文获取类型
收费全文 | 136052篇 |
免费 | 7685篇 |
国内免费 | 883篇 |
专业分类
耳鼻咽喉 | 1445篇 |
儿科学 | 3962篇 |
妇产科学 | 2881篇 |
基础医学 | 18919篇 |
口腔科学 | 5343篇 |
临床医学 | 12083篇 |
内科学 | 31819篇 |
皮肤病学 | 3052篇 |
神经病学 | 13303篇 |
特种医学 | 3655篇 |
外国民族医学 | 1篇 |
外科学 | 14307篇 |
综合类 | 481篇 |
一般理论 | 54篇 |
预防医学 | 11875篇 |
眼科学 | 2208篇 |
药学 | 9007篇 |
中国医学 | 481篇 |
肿瘤学 | 9744篇 |
出版年
2024年 | 142篇 |
2023年 | 1315篇 |
2022年 | 2759篇 |
2021年 | 4708篇 |
2020年 | 2927篇 |
2019年 | 3957篇 |
2018年 | 4532篇 |
2017年 | 3486篇 |
2016年 | 4002篇 |
2015年 | 4372篇 |
2014年 | 5776篇 |
2013年 | 7418篇 |
2012年 | 11375篇 |
2011年 | 11627篇 |
2010年 | 6385篇 |
2009年 | 5489篇 |
2008年 | 9257篇 |
2007年 | 9353篇 |
2006年 | 8552篇 |
2005年 | 7954篇 |
2004年 | 7124篇 |
2003年 | 6357篇 |
2002年 | 5703篇 |
2001年 | 788篇 |
2000年 | 592篇 |
1999年 | 802篇 |
1998年 | 1002篇 |
1997年 | 822篇 |
1996年 | 687篇 |
1995年 | 574篇 |
1994年 | 539篇 |
1993年 | 450篇 |
1992年 | 389篇 |
1991年 | 275篇 |
1990年 | 269篇 |
1989年 | 227篇 |
1988年 | 251篇 |
1987年 | 199篇 |
1986年 | 196篇 |
1985年 | 170篇 |
1984年 | 181篇 |
1983年 | 171篇 |
1982年 | 198篇 |
1981年 | 140篇 |
1980年 | 146篇 |
1979年 | 110篇 |
1978年 | 102篇 |
1977年 | 91篇 |
1976年 | 72篇 |
1974年 | 73篇 |
排序方式: 共有10000条查询结果,搜索用时 12 毫秒
991.
Andra Araujo Brando Weimar Kunz Sebba Barroso Audes Feitosa Eduardo Costa Duarte Barbosa Roberto Dischinger Miranda Priscila Valverde de Oliveira Vitorino Roberto Pozzan Lucio Paulo Ribeiro Abraham Epelman Giovanni Alves Saraiva Fabio Serra Silveira Antnio Almeida Braga Marco Mota Gomes 《Arquivos brasileiros de cardiologia》2022,119(2):353
992.
Cludia Farinha Patrícia Barreto Rita Coimbra Adela Iutis Maria Luz Cachulo Jos Cunha-Vaz Yara T. E. Lechanteur Carel B. Hoyng Rufino Silva 《Investigative ophthalmology & visual science》2022,63(9)
PurposeTo determine the association between rare genetic variants in complement factor H (CFH) and phenotypic features in age-related macular degeneration (AMD) patients from the Coimbra Eye Study (CES).MethodsAMD patients from the Incidence CES () underwent ophthalmologic examination and color fundus photography, spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence, and near-infrared imaging. Multimodal phenotypic characterization was carried out in a centralized reading center. The coding and splice-site regions of the CFH gene were sequenced through single-molecule molecular inversion probe–based next-generation sequencing in association with the EYE-RISK consortium. Variants with minor allele frequency <0.05 resulting in splice-site or protein change were selected. Differences in phenotypic features between carriers and noncarriers were analyzed using generalized estimated equations logistic regression models, considering intereye correlations.ResultsWe included 39 eyes of 23 patients carrying rare CFH variants and 284 eyes of 188 noncarriers. Carrier status was associated with having higher drusen burden in the macula in the inner Early Treatment Diabetic Retinopathy Study circle (odds ratio [OR], 5.44 [95% confidence interval {CI}, 1.61–18.37]; P = 0.006), outer circle (OR, 4.37 [95% CI, 1.07–17.77]; P = 0.04), and full grid (OR, 4.82 [95% CI, 1.13–20.52]; P = 0.033). In SD-OCT, a lower total macular volume and lower inner retinal layers’ volume (OR, 0.449 [95% CI, 0.226–0.894]; P = 0.023; OR, 0.496 [95% CI, 0.252–0.979]; P = 0.043) and pigment epithelial detachments (PEDs) (OR, 5.24 [95% CI, 1.08–25.44]; P = 0.04) were associated with carrying a rare CFH variant. Carriers with subretinal drusenoid deposits (SDD) had the rare variant P258L in all cases except one.ConclusionsWe identified in our cohort phenotypic differences between carriers and noncarriers of rare variants in the CFH gene. Carriers had more severe disease, namely superior drusen burden, PEDs, and thinner retinas. The rare variant P258L may be associated with SDD. Carriers are probably at increased risk of progression. NCT02748824相似文献
993.
Mackenzie A. Hamilton Ying Liu Andrew Calzavara Maria E. Sundaram Mohamed Djebli Dariya Darvin Stefan Baral Rafal Kustra Jeffrey C. Kwong Sharmistha Mishra 《Influenza and other respiratory viruses》2022,16(6):1072
BackgroundShared and divergent predictors of clinical severity across respiratory viruses may support clinical and community responses in the context of a novel respiratory pathogen.MethodsWe conducted a retrospective cohort study to identify predictors of 30‐day all‐cause mortality following hospitalization with influenza (N = 45,749; 2010‐09 to 2019‐05), respiratory syncytial virus (RSV; N = 24 345; 2010‐09 to 2019‐04), or severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2; N = 8988; 2020‐03 to 2020‐12; pre‐vaccine) using population‐based health administrative data from Ontario, Canada. Multivariable modified Poisson regression was used to assess associations between potential predictors and mortality. We compared the direction, magnitude, and confidence intervals of risk ratios to identify shared and divergent predictors of mortality.ResultsA total of 3186 (7.0%), 697 (2.9%), and 1880 (20.9%) patients died within 30 days of hospital admission with influenza, RSV, and SARS‐CoV‐2, respectively. Shared predictors of increased mortality included older age, male sex, residence in a long‐term care home, and chronic kidney disease. Positive associations between age and mortality were largest for patients with SARS‐CoV‐2. Few comorbidities were associated with mortality among patients with SARS‐CoV‐2 as compared with those with influenza or RSV.ConclusionsOur findings may help identify patients at greatest risk of illness secondary to a respiratory virus, anticipate hospital resource needs, and prioritize local prevention and therapeutic strategies to communities with higher prevalence of risk factors. 相似文献
994.
Patrícia Gon?alves Pinheiro Gilvandete Maria Pinheiro Santiago Francisco Erivaldo Freitas da Silva Ana Carolina Justino de Araújo Cícera Rejane Tavares de Oliveira Priscilla Ramos Freitas Janaína Esmeraldo Rocha JoséBezerra de Araújo Neto Maria Milene Costa da Silva Saulo Relison Tintino Irwin Rose Alencar de Menezes Henrique Douglas Melo Coutinho JoséGalberto Martins da Costa 《Asian Pacific Journal of Tropical Biomedicine》2021,(9):405-413
Objective: To evaluate the inhibitory activity of ferulic acid and four of its esterified derivatives (methyl, ethyl, propyl, and butyl) against resistance mech... 相似文献
995.
996.
Manoj Kumar Reddy Somagutta Nishat Shama Maria Kezia Lourdes Pormento Ravi Pankajbhai Jagani Ngaba Neguemadji Ngardig Klodin Ghazarian Greta Mahmutaj Khaled El-Faramawy Ashwini Mahadevaiah Molly Sanjay Jain 《Reumatologia》2022,60(1):63
Statins are a class of lipid-lowering medications used worldwide by millions of people and are safe for frequent use in most patients. However, they cause necrotizing autoimmune myopathy in some patients. We reviewed case reports of 80 patients from 2010 to present diagnosed with statin-induced necrotizing autoimmune myopathy (SINAM), aiming to analyze the clinical, physiological, serologic characteristics and outcomes of SINAM. The mean age of these patients was 66 ±9.4, the majority being male (61.3%). All patients reported proximal muscle weakness, and a few had myalgias, extra muscular symptoms such as dysphagia, and pulmonary complications. Most of the patients were on atorvastatin, simvastatin, or rosuvastatin. The mean creatine kinase was 10,094.2 ±7,351.7 U/l, and anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase enzyme was positive for 93.8% of patients. The majority of patients were started on steroids; other treatments were also used. Prompt cessation of statins and initiation of immunosuppressants reduced morbidity and mortality. 相似文献
997.
Simon P. Jochems Karin de Ruiter Carla Solrzano Astrid Voskamp Elena Mitsi Elissavet Nikolaou Beatriz F. Carniel Sherin Pojar Esther L. German Jesús Rein Alessandra Soares-Schanoski Helen Hill Rachel Robinson Angela D. Hyder-Wright Caroline M. Weight Pascal F. Durrenberger Robert S. Heyderman Stephen B. Gordon Hermelijn H. Smits Britta C. Urban Jamie Rylance Andrea M. Collins Mark D. Wilkie Lepa Lazarova Samuel C. Leong Maria Yazdanbakhsh Daniela M. Ferreira 《The Journal of clinical investigation》2022,132(11)
998.
Dipesh E. Patel Phillippa M. Cumberland Bronwen C. Walters Joseph Abbott John Brookes Beth Edmunds Peng Tee Khaw Ian Christopher Lloyd Maria Papadopoulos Velota Sung Mario Cortina-Borja Jugnoo S. Rahi For the OPTIC Study Group 《Eye (London, England)》2022,36(6):1281
BackgroundPerimetry is important in the management of children with glaucoma, but there is limited evidence-based guidance on its use. We report an expert consensus-based study to update guidance and identify areas requiring further research.MethodsExperts were invited to participate in a modified Delphi consensus process. Panel selection was based on clinical experience of managing children with glaucoma and UK-based training to minimise diversity of view due to healthcare setting. Questionnaires were delivered electronically, and analysed to establish ‘agreement’. Divergence of opinions was investigated and resolved where possible through further iterations.Results7/9 experts invited agreed to participate. Consensus (≥5/7 (71%) in agreement) was achieved for 21/26 (80.8%) items in 2 rounds, generating recommendations to start perimetry from approximately 7 years of age (IQR: 6.75–7.25), and use qualitative methods in conjunction with automated reliability indices to assess test quality. There was a lack of agreement about defining progressive visual field (VF) loss and methods for implementing perimetry longitudinally.Panel members highlighted the importance of informing decisions based upon individual circumstances—from gauging maturity/capability when selecting tests and interpreting outcomes, to accounting for specific clinical features (e.g. poor IOP control and/or suspected progressive VF loss) when making decisions about frequency of testing.ConclusionsThere is commonality of expert views in relation to implementing perimetry and interpreting test quality in the management of children with glaucoma. However, there remains a lack of agreement about defining progressive VF loss, and utilising perimetry over an individuals’ lifetime, highlighting the need for further research.Subject terms: Paediatrics, Glaucoma 相似文献
999.
Antonio Alexander MorganLopez Lissette Maria Saavedra Derek D. Ramirez Luke M. Smith Anna Catherine Yaros 《International journal of methods in psychiatric research》2022,31(2)
ObjectiveOne of the primary tools in the assessment of individual‐level patient outcomes is Jacobson and Truax, (1991’s) Reliable Change Index (RCI). Recent efforts to optimize the RCI have revolved around three issues: (a) extending the RCI beyond two timepoints, (b) estimating the RCI using scale scores from item response theory or factor analysis and (c) estimation of person‐ and time‐specific standard errors of measurement.MethodWe present an adaptation of a two‐stage procedure, a measurement error‐corrected multilevel model, as a tool for RCI estimation (with accompanying Statistical Analysis System syntax). Using DASS‐21 data from a community‐based mental health center (N = 379), we illustrate the potential for the model as unifying framework for simultaneously addressing all three limitations in modeling individual‐level RCI estimates.ResultsCompared to the optimal‐fitting RCI model (moderated nonlinear factor analysis scoring with measurement error correction), an RCI model that uses DASS‐21 total scores produced errors in RCI inferences in 50.8% of patients; this was largely driven by overestimation of the proportion of patients with statistically significant improvement.ConclusionEstimation of the RCI can now be enhanced by the use of latent variables, person‐ and time‐specific measurement errors, and multiple timepoints. 相似文献
1000.
Marina Gonzalez-Ramirez Rocio Sanchez-Carrera Angela Cejudo-Lopez Mauricio Lozano-Navarrete Elena Salamero Snchez-Gabriel M. Alfonso Torres-Bengoa Manuel Segura-Balbuena Maria J. Sanchez-Cordero Mercedes Barroso-Vazquez Francisco J. Perez-Barba Ana M. Troncoso M. Carmen Garcia-Parrilla Ana B. Cerezo 《Nutrients》2022,14(10)
Promoting a healthy diet is a relevant strategy for preventing non-communicable diseases. This study aims to evaluate the impact of an innovative tool, the SAlBi educa nutrition app, in primary healthcare dietary counseling to improve dietary profiles as well as adherence to the Mediterranean diet. A multi-center randomized control trial comprising 104 participants was performed. Both control (n = 49) and intervention (n = 55) groups attended four once-weekly sessions focusing on healthy eating habits and physical activity, over one month. As well as attending the meetings, the intervention group used the app, which provides self-monitoring and tailored dietary advice based on the Mediterranean diet model. In a second intervention (one arm trial), the potential of SAlBi educa was evaluated for three months during the COVID-19 pandemic. At 4 weeks, the intervention group had significantly increased their carbohydrate intake (7.7% (95% CI: 0.16 to 15.2)) and decreased their total fat intake (−5.7% (95% CI: −10.4 to −1.15)) compared to the control group. Significant differences were also found for carbohydrates (3.5% (95% CI: −1.0 to 5.8)), total fats (−5.9% (95% CI: −8.9 to −3.0)), fruits and vegetables (266.3 g/day (95% CI: 130.0 to 402.6)), legumes (7.7g/day (95% CI: 0.2 to 15.1)), starchy foods (36.4 g/day (95% CI: 1.1 to 71.7)), red meat (−17.5 g/day (95% CI: −34.0 to −1.1)), and processed meat (−6.6 g/day (95% CI: −13.1 to −0.1)) intakes during the COVID-19 pandemic. SAlBi educa is a useful tool to support nutrition counseling in primary healthcare, including in special situations such as the COVID-19 pandemic. Trial registration: ISRCTN57186362. 相似文献